These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37541641)

  • 1. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
    Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
    Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
    Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
    Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression.
    Wang S; Wang K; Yue D; Yang X; Pan X; Kong F; Zhao R; Bie Q; Tian D; Zhu S; He B; Bin Z
    Br J Cancer; 2024 Sep; 131(4):641-654. PubMed ID: 38906969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
    Wang R; Zhao J; Jin J; Tian Y; Lan L; Wang X; Zhu L; Wang J
    Lipids Health Dis; 2022 Nov; 21(1):121. PubMed ID: 36384580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KAT7 suppresses tumorigenesis in clear cell renal cell carcinoma (ccRCC) by regulating cell cycle and ferroptosis sensitivity.
    Hong G; Chen W; Gong M; Wu Y; Shu G; Xiao Y; Zhang T; ShuXiong X
    Exp Cell Res; 2024 Aug; 441(2):114149. PubMed ID: 38960363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ is dispensable for clear cell renal cell carcinoma progression.
    Sanchez DJ; Steger DJ; Skuli N; Bansal A; Simon MC
    Mol Metab; 2018 Aug; 14():139-149. PubMed ID: 29866440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid in Renal Carcinoma: Queen Bee to Target?
    Tan SK; Welford SM
    Trends Cancer; 2020 Jun; 6(6):448-450. PubMed ID: 32459999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma.
    Huang T; Tian W; Zhou Q; Li J; Jiang Z; Chen J; Ge C; Tian H
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):988-996. PubMed ID: 34133712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer.
    Guo X; Wang A; Wang W; Wang Y; Chen H; Liu X; Xia T; Zhang A; Chen D; Qi H; Ling T; Piao HL; Wang HJ
    Mol Oncol; 2021 Feb; 15(2):642-656. PubMed ID: 33207079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARMA3 Transcriptional Regulation of STMN1 by NF-κB Promotes Renal Cell Carcinoma Proliferation and Invasion.
    Shi D; Zhang Z; Kong C
    Technol Cancer Res Treat; 2021; 20():15330338211027915. PubMed ID: 34190011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling.
    Yang H; Zhang X; Liu F; Fan J; Wang B; Dong C
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1383-1388. PubMed ID: 29183723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway.
    Li L; Li M; Zheng J; Li Z; Chen X
    Aging (Albany NY); 2023 Jun; 15(11):4757-4773. PubMed ID: 37263638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
    Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
    J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
    Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
    Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
    Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
    Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
    [No Abstract]   [Full Text] [Related]  

  • 19. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.
    Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y
    Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
    Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q
    Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.